XTRAPRED – A topical ophthalmic solution for eyes

XTRAPRED – A topical ophthalmic solution for eyes

 

Prednisolone is the fluorinated carboxyquinolone in the suspension for the topical ophthalmic usage.

Description

Prednisolone is the fluorinated carboxyquinolone in the suspension for the topical ophthalmic usage.

Highlights

Prednisolone is the potent steroid in the topical form

Indications

XTRAPRED suspension is specified mainly for uveitis treatment. It can be also utilized in the steroid-responsive inflammation for bulbar and palpebral conjunctiva, anterior, and cornea segment in the world. 

Dosage & Administration

You need to shake well before use. Infuse one drop into conjunctival sac with 2-4 times everyday. During the first 24-48 hours, dosing frequency can be increased if required. Care needs to be taken, however, not to discontinue the therapy prematurely. In case, the symptoms fail to get better after 1-2 days, patient needs to be re-evaluated.

Adverse Reaction

The most commonly reported drug-associated adverse reaction is temporary ocular discomfort or burning. Long-term adverse reactions incorporate, in the decreasing frequency order, increase of IOP (Intra Ocular Pressure), having possible glaucoma development or occasional optic nerve damage, subsequent sub capsular cataract arrangement, and deferred wound healing. Some other effects like conjunctivitis, Keratitis, mydriasis, corneal ulcers, and loss of accommodation, conjunctival hyperemia, with ptosis have infrequently been reported following the local usage of corticosteroids. The secondary ocular fungal development or the viral infection can be happened. Viral and fungal infections of cornea are predominantly prone to develop accidentally with the long-term steroid applications. The fungal invasion possibility should be measured in any of the determined corneal ulceration where the steroid treatment is used. Other reported adverse reactions consist of redness, itching, stinging, keratitis, chemical conjunctivitis, foreign body sensation, facial edema, blurred vision, photophobia, eye pain, tearing, and dryness. Exceptional reports of dizziness are also received.

Precautions

Prolonged use of the corticosteroids can result into glaucoma with the damage to optic nerve, blemishes in visual acuity, posterior sub capsular cataract development, and fields of vision. Prolonged use can also suppress host immune response as well as increase secondary ocular infections hazards. Different ocular diseases as well as long-term usage of topical corticosteroids are known to source scleral and corneal thinning. Using topical corticosteroids with thin scleral or corneal tissue can result into perforation. Acute eye purulent infections can be masked or the activity enhanced by occurrence of the corticosteroid medication. In case, this product is utilized for more than 10 days, pressure of intraocular needs to be routinely monitored although it can be difficult in the children as well as uncooperative patients. The steroids need to be utilized with the caution in occurrence of glaucoma. Intraocular pressure needs to be checked commonly. It encloses the sodium bisulfite, the sulfite, which can cause the allergic-type reactions, with anaphylactic symptoms with life-threatening and less strict asthmatic episodes in definite susceptible people. Overall sulfite sensitivity prevalence in common population is probably low and unknown. Sulfite sensitivity is more frequently seen in asthmatics than in the non-asthmatic people. 

General: The primary renewal and prescription of medication order further than 20 milliliters of the XTRAPRED needs to be made by the physician after the patient examination with aid of exaggeration, like slit-lamp bio-microscopy, furthermore, where suitable, fluorescein staining. In case, the symptoms fail to get better after 2 days, patient needs to be re-evaluated. While the cornea fungal infections are mainly prone to develop accidentally with the long-term limited corticosteroid applications, the fungal invasion needs to be suspected within any constant corneal ulceration where the corticosteroid is used or in use. The fungal cultures need to be taken if applicable. If the product is utilized for more than 10 days, the intraocular pressure needs to be monitored Mutagenesis, Carcinogenesis, and Impairment of Fertility. No studies are conducted within the in humans or animals to evaluate possible for these effects. 

Use in pregnancy: No adequate as well as well-controlled studies are available for pregnant women. The XTRAPRED needs to be used during the pregnancy in case; the possible benefit justifies potential risk to fetus. 

Use in Lactation: This is unknown whether the topical ophthalmic management of the corticosteroids might result into sufficient systemic absorption for producing detectable quantities of breast milk. 

Use in Children: Effectiveness and safety in the pediatric patients are not established.

Image Source: Picasa